Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro

Br J Ophthalmol. 2007 Jan;91(1):100-4. doi: 10.1136/bjo.2006.098004. Epub 2006 Sep 20.

Abstract

Objective: To investigate the expression of proangiogenic and antiangiogenic factors, vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in retinal pigment epithelial (RPE) cells after photodynamic therapy (PDT), especially focusing on their change in the presence of triamcinolone acetonide.

Methods: Firstly, the cellular uptake of verteporfin was quantified after confluent ARPE-19 (human retinal pigment epithelial) cells were exposed to 5 microg/ml verteporfin combined with or without 1 microg/ml triamcinolone acetonide for 1 h. Secondly, ARPE-19 cells exposed to various doses of verteporfin were irradiated with 120 mJ/cm(2) light. After incubation with or without 1 microg/ml triamcinolone acetonide for 2 days, cell viability and expressions of VEGF and PEDF were assessed.

Results: Cellular uptake of verteporfin was not significantly changed by the presence of 1 microg/ml triamcinolone acetonide. In addition, 0.01-0.1 microg/ml of verteporfin showed a dose-dependent toxicity on the ARPE-19 cells 2 days after the light exposure. The presence of verteporfin at a concentration of 0.01 microg/ml did not affect the cell viability but significantly increased VEGF (p<0.001) and reduced PEDF (p = 0.03) expression. Administration of triamcinolone acetonide significantly suppressed both this increase in VEGF (p<0.001) and decrease in PEDF (p = 0.001).

Conclusions: VEGF was increased and PEDF reduced in cultured RPE cells shortly after PDT even at a sublethal dose. Triamcinolone acetonide suppressed this proangiogenic response.

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay / methods
  • Eye Proteins / analysis
  • Glucocorticoids / pharmacology*
  • Humans
  • Neovascularization, Pathologic / drug therapy*
  • Nerve Growth Factors / analysis
  • Photochemotherapy / methods*
  • Photosensitizing Agents / pharmacology
  • Pigment Epithelium of Eye / blood supply*
  • Pigment Epithelium of Eye / drug effects
  • Porphyrins / pharmacokinetics
  • Porphyrins / pharmacology
  • Protease Inhibitors / analysis
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Serpins / analysis
  • Triamcinolone Acetonide / pharmacology*
  • Vascular Endothelial Growth Factor A / analysis
  • Verteporfin

Substances

  • Eye Proteins
  • Glucocorticoids
  • Nerve Growth Factors
  • Photosensitizing Agents
  • Porphyrins
  • Protease Inhibitors
  • RNA, Messenger
  • Serpins
  • Vascular Endothelial Growth Factor A
  • pigment epithelium-derived factor
  • Verteporfin
  • Triamcinolone Acetonide